CIPROXAN Side Effects

6628733-7 | Affective Disorder, Hallucination, Visual
on Feb 25, 2010 Male patient from JAPAN , 80 years of age, was treated with Ciproxan (View Usage). Patient experienced the following unwanted or unexpected effects: affective disorder, hallucination, visual. Ciproxan dosage: .

6617216-6 | Haematuria, Haemolytic Anaemia
Patient was taking Ciproxan (View Usage). Patient had the following side effects: haematuria, haemolytic anaemia on Nov 04, 2008 from UNITED STATES Additional patient health information: Male patient , 58 years of age, . Ciproxan dosage: . During the same period patient was treated with ENTECAVIR (View Entecavir Review and Entecavir Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), CLEXANE (View Clexane Review and Clexane Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6543066-5 | Pseudomembranous Colitis, Sepsis
Adverse event was reported on Jan 13, 2010 by a Male patient taking Ciproxan (View Usage) (Dosage: ) was diagnosed with pyrexia, idiopathic pulmonary fibrosis and. Location: JAPAN , 78 years of age, After Ciproxan was administered, patient had the following side effects: pseudomembranous colitis, sepsis (What is sepsis?). During the same period patient was treated with PENMALIN (View Penmalin Review and Penmalin Label ), OMEGACIN (View Omegacin Review and Omegacin Label ), PIRESPA (Total Daily Dose: 1800 Mg) (View Pirespa Review and Pirespa Label ), NOVOLIN R (View Novolin R Review and Novolin R Label ), NOVORAPID (View Novorapid Review and Novorapid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6438064-6 | Pseudomembranous Colitis, Sepsis
on Nov 06, 2009 Male patient from JAPAN , 78 years of age, was diagnosed with pneumonia (What is pneumonia?), idiopathic pulmonary fibrosis and was treated with Ciproxan (View Usage). Patient experienced the following unwanted or unexpected effects: pseudomembranous colitis, sepsis (What is sepsis?). Ciproxan dosage: . During the same period patient was treated with PENMALIN (View Penmalin Review and Penmalin Label ), OMEGACIN (View Omegacin Review and Omegacin Label ), PIRESPA (Total Daily Dose: 1800 Mg) (View Pirespa Review and Pirespa Label ), NOVOLIN R (View Novolin R Review and Novolin R Label ), NOVORAPID (View Novorapid Review and Novorapid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).


6387122-3 | Chest X-ray Abnormal, Computerised Tomogram Abnormal, Dyspnoea, Interstitial Lung Disease, Pyrexia
on Sep 29, 2009 Female patient from JAPAN , 49 years of age, weighting 88.18 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ciproxan (View Usage). Patient had the following side effects: chest x-ray abnormal, computerised tomogram abnormal, dyspnoea, interstitial lung disease, pyrexia. Ciproxan dosage: Total Daily Dose: 1200 Mg Unit Dose: 200 Mg. During the same period patient was treated with NAVELBINE (Twice Per 3 Days) (View Navelbine Review and Navelbine Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), FERROMIA (View Ferromia Review and Ferromia Label ), MYSTAN (View Mystan Review and Mystan Label ), LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ), ZOMETA (View Zometa Review and Zometa Label ). Patient was hospitalized.

6366512-9 | Chest X-ray Abnormal, Computerised Tomogram Abnormal, Dyspnoea, Interstitial Lung Disease, Pyrexia
Patient was taking Ciproxan (View Usage). After Ciproxan was administered, patient had the following side effects: chest x-ray abnormal, computerised tomogram abnormal, dyspnoea, interstitial lung disease, pyrexia on Sep 15, 2009 from JAPAN Additional patient health information: Female patient , 49 years of age, weighting 88.18 lb, was diagnosed with breast cancer (What is breast cancer?) and. Ciproxan dosage: Total Daily Dose: 1200 Mg Unit Dose: 200 Mg. During the same period patient was treated with HERCEPTIN (View Herceptin Review and Herceptin Label ), NAVELBINE (Twice Per 3 Days) (View Navelbine Review and Navelbine Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), FERROMIA (View Ferromia Review and Ferromia Label ), MYSTAN (View Mystan Review and Mystan Label ), LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ), ZOMETA (View Zometa Review and Zometa Label ). Patient was hospitalized.

6261423-1 | Chest X-ray Abnormal, Computerised Tomogram Abnormal, Dyspnoea, Pyrexia
Adverse event was reported on Jul 06, 2009 by a Female patient taking Ciproxan (View Usage) (Dosage: Total Daily Dose: 1200 Mg Unit Dose: 200 Mg) . Location: JAPAN , 49 years of age, weighting 94.80 lb, Patient experienced the following unwanted or unexpected effects: chest x-ray abnormal, computerised tomogram abnormal, dyspnoea, pyrexia. During the same period patient was treated with HERCEPTIN (View Herceptin Review and Herceptin Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), FERROMIA (View Ferromia Review and Ferromia Label ), MYSTAN (View Mystan Review and Mystan Label ), LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ), ZOMETA (View Zometa Review and Zometa Label ), NAVELBINE (View Navelbine Review and Navelbine Label ). Patient was hospitalized.

6259689-7 | Bedridden, Corneal Epithelial Microcysts, Oral Mucosa Erosion
on Jul 02, 2009 Female patient from JAPAN , 75 years of age, was diagnosed with cystitis and was treated with Ciproxan (View Usage). Patient had the following side effects: bedridden, corneal epithelial microcysts, oral mucosa erosion. Ciproxan dosage: Total Daily Dose: 300 Mg Unit Dose: 100 Mg.

6233971-1 | Haemoptysis, International Normalised Ratio Increased
on Jun 16, 2009 Male patient from JAPAN , 59 years of age, weighting 158.7 lb, was diagnosed with pneumonia (What is pneumonia?), atrial fibrillation (What is atrial fibrillation?), gastric ulcer, hepatic function abnormal, diarrhoea and was treated with Ciproxan (View Usage). After Ciproxan was administered, patient had the following side effects: haemoptysis, international normalised ratio increased. Ciproxan dosage: Total Daily Dose: 400 Mg. During the same period patient was treated with WARFARIN SODIUM (Total Daily Dose: 1.5 Mg) (View Warfarin Sodium Review and Warfarin Sodium Label ), GARENOXACIN MESILATE HYDRATE (View Garenoxacin Mesilate Hydrate Review and Garenoxacin Mesilate Hydrate Label ), UNASYN (Total Daily Dose: 6 G Unit Dose: 3 G) (View Unasyn Review and Unasyn Label ), PROTECADIN (Total Daily Dose: 20 Mg Unit Dose: 10 Mg) (View Protecadin Review and Protecadin Label ), URSO 250 (Total Daily Dose: 300 Mg Unit Dose: 100 Mg) (View Urso 250 Review and Urso 250 Label ), BIOFERMIN R (Total Daily Dose: 3 G Unit Dose: 1 G) (View Biofermin R Review and Biofermin R Label ). Patient was hospitalized.

6156459-5 | Arterial Bypass Operation, Haematuria, Haemolytic Anaemia
Patient was taking Ciproxan (View Usage). Patient experienced the following unwanted or unexpected effects: arterial bypass operation, haematuria, haemolytic anaemia on Apr 15, 2009 from UNITED STATES Additional patient health information: Male patient , 58 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Ciproxan dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), CLEXANE (View Clexane Review and Clexane Label ), ENTEZAVIR (View Entezavir Review and Entezavir Label ).

6086013-5 | Anaphylactic Reaction, Anaphylactoid Reaction, Urticaria
Adverse event was reported on Feb 13, 2009 by a Female patient taking Ciproxan (View Usage) (Dosage: ) . Location: JAPAN , 16 years of age, Patient had the following side effects: anaphylactic reaction, anaphylactoid reaction, urticaria. During the same period patient was treated with BRUFEN (View Brufen Review and Brufen Label ), PL (View Pl Review and Pl Label ).

6052845-2 | Anaphylactic Shock, Anaphylactoid Reaction, Urticaria
on Jan 23, 2009 Female patient from JAPAN , 16 years of age, was diagnosed with unevaluable event and was treated with Ciproxan (View Usage). After Ciproxan was administered, patient had the following side effects: anaphylactic shock, anaphylactoid reaction, urticaria. Ciproxan dosage: . During the same period patient was treated with BRUFEN (View Brufen Review and Brufen Label ), PL (View Pl Review and Pl Label ).

5952970-8 | Arterial Bypass Operation, Haematuria, Haemolytic Anaemia
on Nov 04, 2008 Male patient from UNITED STATES , 58 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Ciproxan (View Usage). Patient experienced the following unwanted or unexpected effects: arterial bypass operation, haematuria, haemolytic anaemia. Ciproxan dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), CLEXANE (View Clexane Review and Clexane Label ), ENTEZAVIR (View Entezavir Review and Entezavir Label ).

5944543-8 | Haematuria, Haemolytic Anaemia
Patient was taking Ciproxan (View Usage). Patient had the following side effects: haematuria, haemolytic anaemia on Nov 04, 2008 from UNITED STATES Additional patient health information: Male patient , 58 years of age, . Ciproxan dosage: . During the same period patient was treated with ENTECAVIR (View Entecavir Review and Entecavir Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), CLEXANE (View Clexane Review and Clexane Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).